FDCDDQ
CAPR icon

Federation des caisses Desjardins du Quebec’s Capricor Therapeutics CAPR Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6K Hold
856
– – ﹤0.01% 2178
2026
Q1 		$26K Hold
856
– – ﹤0.01% 2038
2025
Q4 		$24.7K Sell
856
-250
-23% -$3.27K ﹤0.01% 2008
2025
Q3 		$7.97K Hold
1,106
– – ﹤0.01% 2328
2025
Q2 		$11K Sell
1,106
-626
-36% -$6.61K ﹤0.01% 2006
2025
Q1 		$16.4K Hold
1,732
– – ﹤0.01% 1795
2024
Q4 		$23.9K Sell
1,732
-326
-16% -$5.71K ﹤0.01% 1622
2024
Q3 		$31.3K Buy
2,058
+126
+7% +$623 ﹤0.01% 1530
2024
Q2 		$9.22K Hold
1,932
– – ﹤0.01% 1831
2024
Q1 		$13.1K Hold
1,932
– – ﹤0.01% 1758
2023
Q4 		$9.45K Hold
1,932
– – ﹤0.01% 1766
2023
Q3 		$6.61K Hold
1,932
– – ﹤0.01% 1849
2023
Q2 		$9.23K Hold
1,932
– – ﹤0.01% 1781
2023
Q1 		$8.15K Hold
1,932
– – ﹤0.01% 1812
2022
Q4 		$7.46K Hold
1,932
– – ﹤0.01% 1944
2022
Q3 		$11.6K Sell
1,932
-3,374
-64% -$17.3K ﹤0.01% 1876
2022
Q2 		$18.5K Hold
5,306
– – ﹤0.01% 1784
2022
Q1 		$18.2K Hold
5,306
– – ﹤0.01% 1852
2021
Q4 		$15.5K Hold
5,306
– – ﹤0.01% 1912
2021
Q3 		$21.3K Hold
5,306
– – ﹤0.01% 1837
2021
Q2 		$27.2K Sell
5,306
-27,994
-84% -$119K ﹤0.01% 1773
2021
Q1 		$156K Buy
33,300
+24,000
+258% +$138K ﹤0.01% 1193
2020
Q4 		$31.9K Sell
9,300
-10,450
-53% -$45.3K ﹤0.01% 1624
2020
Q3 		$104K Buy
19,750
+6,300
+47% +$36.7K ﹤0.01% 1049
2020
Q2 		$61.9K Buy
+13,450
New +$58.6K ﹤0.01% 1161

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's CAPR Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Capricor Therapeutics (CAPR) position steady in Q2 2026 at 856 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2178.

Federation des caisses Desjardins du Quebec first reported a position in CAPR in Q2 2020 and has held it in 25 quarters since. The position peaked at $156K in Q1 2021. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 856 shares of Capricor Therapeutics worth $20.6K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec left its Capricor Therapeutics share count unchanged in Q2 2026.
  • Capricor Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2178 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Capricor Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Federation des caisses Desjardins du Quebec's Capricor Therapeutics position peaked at $156K in Q1 2021.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.